Silybin phytosome
Silybin Phytosome (Siliphos) · also known as Silybin, Siliphos, Silymarin phospholipid complex
Silybin is one of the main active compounds in milk thistle and is a flavonolignan. Animal studies show it can upregulate Nrf2 target genes, and it has antioxidant activity in vitro. In humans, none of the proposed mechanisms (acting on Nrf2 targets, direct free-radical scavenging, promoting tissue repair) has been confirmed.
Clinical uses and human evidence
Fatty liver and liver enzymes
Blood sugar and insulin resistance
All-cause mortality risk
Mechanisms of action
Nrf2/ARE activation of endogenous antioxidant enzymes
In an animal model of steatohepatitis, oral silybin increased expression of Nrf2 target genes, which supports modulation of this pathway. However, a direct change in Keap1 conformation and induction of GST and HO-1 in the human liver have not been confirmed.
Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair
In mouse intestinal barrier studies, silybin-associated changes in the gut microbiota were accompanied by upregulation of tight junction proteins. This is not the same as improved liver microcirculation or a better bile duct epithelial barrier. Tight junction repair in humans after taking the phospholipid complex orally has not been directly shown.
Direct free radical trapping and chemical quenching
Silybin has antioxidant activity in vitro, and oxidative stress markers improved in an animal model of steatohepatitis, but these changes were accompanied by changes in several signaling pathways. Whether it directly intercepts lipid peroxidation chain reactions within membranes, and how much it contributes to direct scavenging after oral dosing in humans, both remain unclear.